{
    "response": "Imaging and CSF studies are required to confirm demyelinating disease and demonstrate dissemination in space and time, while antibody tests and metabolic, autoimmune, and infectious screens help distinguish MS from mimics and ensure safety before immunotherapy.\n\ninvestigations = [\"MRI of brain, orbits and whole spine with gadolinium\", \"Lumbar puncture with CSF cell count, protein, glucose, oligoclonal bands and IgG index\", \"Visual evoked potentials\", \"Optical coherence tomography of optic nerves and maculae\", \"Serum aquaporin-4 IgG antibodies\", \"Serum MOG IgG antibodies\", \"Full blood count\", \"Urea and electrolytes\", \"Liver function tests\", \"C-reactive protein\", \"Erythrocyte sedimentation rate\", \"Blood glucose\", \"Vitamin B12 level\", \"Folate level\", \"Serum copper and ceruloplasmin\", \"Thyroid function tests\", \"Antinuclear antibody\", \"Extractable nuclear antigen panel\", \"Antiphospholipid antibody panel\", \"Serum ACE level\", \"HIV antibody/antigen test\", \"Syphilis serology\", \"Lyme serology\", \"Serum vitamin D level\", \"Pregnancy test\", \"ECG\"]"
}